BD-Func: A streamlined algorithm for predicting activation and inhibition of pathways

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Warden, Charles D ^a   Kanaya, Noriko ^b   Chen, Shiuan ^b   Yuan, Yate Ching ^a  

^a Department of Molecular Medicine ^*  (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bioinformatics; Functional enrichment; Gene set; Genomics; Lbh589; Pathway; Systems biology

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PANOBINOSTAT; PROGESTERONE RECEPTOR; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIDIRECTIONAL FUNCTIONAL ENRICHMENT; BREAST CANCER; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENETIC ALGORITHM; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY;

EID: 84885098590     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.159     Document Type: Article

References (50)

1. Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, Foekens JA, Zhang Y,Wang Y, MarcomK,Marks JR,Mukherjee S, Nevins JR, Blackwell KL, Potti A. 2008. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS ONE 3:e1373 DOI 10.1371/journal.pone.0001373.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S,Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. Nature Genetics 25:25-29 DOI 10.1038/75556.
3. Bardou V-J, Arpino G, Elledge RM, Osborne CK, Clark GM. 2003. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. Journal of Clinical Oncology 21:1973-1979 DOI 10.1200/JCO.2003.09.099.
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57:289-300.
5. Berriz GF, Beaver JE, Cenik C, Tasan M, Roth FP. 2009. Next generation software for functional trend analysis. Bioinformatics 25:3043-3044 DOI 10.1093/bioinformatics/btp498.
6. Bild AH, Yao G, Chang JT,Wang Q, Potti A, Chasse D, Joshi M-B, Harpole D, Lancaster JM, Berchuck A, Olson JA,Marks JR, Dressman HK,West M, Nevins JR. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357 DOI 10.1038/nature04296.
7. Boorsma A, Foat BC, Vis D, Klis F, Bussemaker HJ. 2005. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Research 33:W592-W595 DOI 10.1093/nar/gki484.
8. Chang JT, Nevins JR. 2006. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22:2926-2933 DOI 10.1093/bioinformatics/btl483.
9. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, KuoW-L, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S,Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG,Waldman FM, Gray JW. 2006. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10:529-541 DOI 10.1016/j.ccr.2006.10.009.
10. Claus EB, Park PJ, Carroll R, Chan J, Black PM. 2008. Specific genes expressed in association with progesterone receptors in meningioma. Cancer Research 68:314-322 DOI 10.1158/0008-5472.CAN-07-1796.
11. Dellinger TH, Planutis K, Jandial DD, Eskander RN,Martinez ME, Zi X,Monk BJ, Holcombe RF. 2012. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecologic Oncology 126:259-267 DOI 10.1016/j.ygyno.2012.04.026.
12. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. 2007. A systems biology approach for pathway level analysis. Genome Research 17:1537-1545 DOI 10.1101/gr.6202607.
13. Edelman E, Porrello A, Guinney J, Balakumaran B, Bild A, Febbo PG,Mukherjee S. 2006. Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 22:e108-e116 DOI 10.1093/bioinformatics/btl231.
14. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30:207-210 DOI 10.1093/nar/30.1.207.
15. Elkon R, Rashi-Elkeles S, Lerenthal Y, Linhart C, Tenne T, Amariglio N, Rechavi G, Shamir R, Shiloh Y. 2005. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biology 6:R43 DOI 10.1186/gb-2005-6-5-r43.
16. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. 2008. Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine 14:518-527 DOI 10.1038/nm1764.
17. Furuta S,Wang J-M,Wei S, Jeng Y-M, Jiang X, Gu B, Chen P-L, Lee EYHP, LeeW-H. 2006. Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. Cancer Cell 10:13-24 DOI 10.1016/j.ccr.2006.05.022.
18. Hanzelmann S, Castelo R, Guinney J. 2013. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 14:7 DOI 10.1186/1471-2105-14-7.
19. Huang DW, Sherman BT, Lempicki RA. 2008. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4:44-57 DOI 10.1038/nprot.2008.211.
20. Huang DW, Sherman BT, Lempicki RA. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 37:1-13 DOI 10.1093/nar/gkn923.
21. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM,West M, Nevins JR, Huang AT. 2003. Gene expression predictors of breast cancer outcomes. The Lancet 361:1590-1596 DOI 10.1016/S0140-6736(03)13308-9.
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264 DOI 10.1093/biostatistics/4.2.249.
23. Ivshina AV, George J, Senko O,Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H,Wong JEL, Liu ET, Bergh J, Kuznetsov VA,Miller LD. 2006. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Research 66:10292-10301 DOI 10.1158/0008-5472.CAN-05-4414.
24. Kanehisa M, Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28:27-30 DOI 10.1093/nar/28.1.27.
25. Kim S-Y, Volsky D. 2005. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6:144 DOI 10.1186/1471-2105-6-144.
26. Kubo M, Kanaya N, Petrossian K, Ye J,Warden C, Liu Z, Nishimura R, Osako T, Okido M, Shimada K, Takahashi M, Chu P, Yuan Y-C, Chen S. 2013. Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat). Breast Cancer Research and Treatment 137:93-107 DOI 10.1007/s10549-012-2332-x.
27. Lamb J, Crawford ED, Peck D,Modell JW, Blat IC,Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN, Reich M, Hieronymus H,Wei G, Armstrong SA, Haggarty SJ, Clemons PA,Wei R, Carr SA, Lander ES, Golub TR. 2006. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-1935 DOI 10.1126/science.1132939.
28. Lee H, Braynen W, Keshav K, Pavlidis P. 2005. ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics 6:269 DOI 10.1186/1471-2105-6-269.
29. Liberzon A, Subramanian A, Pinchback R, Thorvaldsd óttir H, Tamayo P,Mesirov JP. 2011. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27:1739-1740 DOI 10.1093/bioinformatics/btr260.
30. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 20:781-810 DOI 10.1146/annurev.cellbio.20.010403.113126.
31. α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 34:267-273 DOI 10.1038/ng1180.
32. Mortazavi A,Williams BA,McCue K, Schaeffer L,Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5:621-628 DOI 10.1038/nmeth.1226.
33. NaeemH, Zimmer R, Tavakkolkhah P, Küffner R. 2012. Rigorous assessment of gene set enrichment tests. Bioinformatics 28:1480-1486 DOI 10.1093/bioinformatics/bts164.
34. Nam D, Kim S-Y. 2008. Gene-set approach for expression pattern analysis. Briefings in Bioinformatics 9:189-197 DOI 10.1093/bib/bbn001.
35. Padua D, Zhang XHF,Wang Q, Nadal C, Gerald WL, Gomis RR,Massagué J. 2008. TGF β primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133:66-77 DOI 10.1016/j.cell.2008.01.046.
36. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, Abeygunawardena N, Berube H, Dylag M, Emam I, Farne A, Holloway E, Lukk M,Malone J,Mani R, Pilicheva E, Rayner TF, Rezwan F, Sharma A,Williams E, Bradley XZ, Adamusiak T, Brandizi M, Burdett T, Coulson R, Krestyaninova M, Kurnosov P,Maguire E, Neogi SG, Rocca-Serra P, Sansone S-A, Sklyar N, Zhao M, Sarkans U, Brazma A. 2009. ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Research 37:D868-D872 DOI 10.1093/nar/gkn889.
37. Partek Inc. 2012. Partek® Genomics Suite, Version 6.6, revision 6.12.1011 ed. St. Louis. Qin H, Chan M, Liyanarachchi S, Balch C, Potter D, Souriraj I, Cheng A, Agosto-Perez F, Nikonova E, Yan P, Lin H-J, Nephew K, Saltz J, Showe L, Huang T, Davuluri R. 2009. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Systems Biology 3:73 DOI 10.1186/1752-0509-3-73.
38. Renzoni E, Abraham D, Howat S, Shi-Wen X, Sestini P, Bou-Gharios G,Wells A, Veeraraghavan S, Nicholson A, Denton C, Leask A, Pearson J, Black C,Welsh K, du Bois R. 2004. Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts. Respiratory Research 5:24 DOI 10.1186/1465-9921-5-24.
39. Sartor MA,Mahavisno V, Keshamouni VG, Cavalcoli J,Wright Z, Karnovsky A, Kuick R, Jagadish HV,Mirel B,Weymouth T, Athey B, Omenn GS. 2010. ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics 26:456-463 DOI 10.1093/bioinformatics/btp683.
40. Scandura JM, Boccuni P,Massagué J, Nimer SD. 2004. Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proceedings of the National Academy of Sciences of the United States of America 101:15231-15236 DOI 10.1073/pnas.0406771101.
41. Sing T, Sander O, Beerenwinkel N, Lengauer T. 2005. ROCR: visualizing classifier performance in R. Bioinformatics 21:3940-3941 DOI 10.1093/bioinformatics/bti623.
42. Sotiriou C, Neo S-Y,McShane LM, Korn EL, Long PM, Jazaeri A,Martiat P, Fox SB, Harris AL, Liu ET. 2003. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America 100:10393-10398 DOI 10.1073/pnas.1732912100.
43. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100:9440-9445 DOI 10.1073/pnas.1530509100.
44. Subramanian A, Tamayo P,Mootha VK,Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES,Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102:15545-15550 DOI 10.1073/pnas.0506580102.
45. Tarca AL, Draghici S, Khatri P, Hassan SS,Mittal P, Kim J-s, Kim CJ, Kusanovic JP, Romero R. 2009. A novel signaling pathway impact analysis (SPIA). Bioinformatics 25(1):75-82 DOI 10.1093/bioinformatics/btn577.
46. The Cancer Genome Atlas Network. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490:61-70 DOI 10.1038/nature11412.
47. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA. 2006. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10:331-342 DOI 10.1016/j.ccr.2006.09.006.
48. Williams G. 2012. A searchable cross-platform gene expression database reveals connections between drug treatments and disease. BMC Genomics 13:12 DOI 10.1186/1471-2164-13-12.
49. Zeeberg B, Feng W,Wang G,Wang M, Fojo A, Sunshine M, Narasimhan S, Kane D, Reinhold W, Lababidi S, Bussey K, Riss J, Barrett J,Weinstein J. 2003. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biology 4:R28 DOI 10.1186/gb-2003-4-4-r28.
50. Zhang B, Kirov S, Snoddy J. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Research 33:W741-W748 DOI 10.1093/nar/gki475.